Standard
Serum tetranectin is a significant prognostic marker in ovarian cancer patients. / Begum, Farah Diba; Høgdall, Estrid; Christensen, Ib Jarle; Kjær, Susanne Kryger; Blaakaer, Jan; Christensen, Lise Hanne; Høgdall, Claus; Kjær, Susanne.
I:
Acta Obstetricia et Gynecologica Scandinavica, Bind 89, Nr. 2, 01.01.2010, s. 190-8.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Begum, FD
, Høgdall, E, Christensen, IJ, Kjær, SK, Blaakaer, J, Christensen, LH
, Høgdall, C & Kjær, S 2010, '
Serum tetranectin is a significant prognostic marker in ovarian cancer patients',
Acta Obstetricia et Gynecologica Scandinavica, bind 89, nr. 2, s. 190-8.
https://doi.org/10.3109/00016340903530936APA
Begum, F. D.
, Høgdall, E., Christensen, I. J., Kjær, S. K., Blaakaer, J., Christensen, L. H.
, Høgdall, C., & Kjær, S. (2010).
Serum tetranectin is a significant prognostic marker in ovarian cancer patients.
Acta Obstetricia et Gynecologica Scandinavica,
89(2), 190-8.
https://doi.org/10.3109/00016340903530936Vancouver
Begum FD
, Høgdall E, Christensen IJ, Kjær SK, Blaakaer J, Christensen LH o.a.
Serum tetranectin is a significant prognostic marker in ovarian cancer patients.
Acta Obstetricia et Gynecologica Scandinavica. 2010 jan. 1;89(2):190-8.
https://doi.org/10.3109/00016340903530936Author
Begum, Farah Diba ; Høgdall, Estrid ; Christensen, Ib Jarle ; Kjær, Susanne Kryger ; Blaakaer, Jan ; Christensen, Lise Hanne ; Høgdall, Claus ; Kjær, Susanne. / Serum tetranectin is a significant prognostic marker in ovarian cancer patients. I: Acta Obstetricia et Gynecologica Scandinavica. 2010 ; Bind 89, Nr. 2. s. 190-8.
Bibtex
@article{2a5ce8560f4147d4af39619af18ddb68,
title = "Serum tetranectin is a significant prognostic marker in ovarian cancer patients",
abstract = "To evaluate the prognostic value of preoperative serum tetranectin (TN) in Danish ovarian cancer (OvCa) patients. Design. Population-based, multidisciplinary Danish case-control study of OvCa.",
author = "Begum, {Farah Diba} and Estrid H{\o}gdall and Christensen, {Ib Jarle} and Kj{\ae}r, {Susanne Kryger} and Jan Blaakaer and Christensen, {Lise Hanne} and Claus H{\o}gdall and Susanne Kj{\ae}r",
year = "2010",
month = jan,
day = "1",
doi = "http://dx.doi.org/10.3109/00016340903530936",
language = "English",
volume = "89",
pages = "190--8",
journal = "Acta Obstetricia et Gynecologica Scandinavica",
issn = "0001-6349",
publisher = "JohnWiley & Sons Ltd",
number = "2",
}
RIS
TY - JOUR
T1 - Serum tetranectin is a significant prognostic marker in ovarian cancer patients
AU - Begum, Farah Diba
AU - Høgdall, Estrid
AU - Christensen, Ib Jarle
AU - Kjær, Susanne Kryger
AU - Blaakaer, Jan
AU - Christensen, Lise Hanne
AU - Høgdall, Claus
AU - Kjær, Susanne
PY - 2010/1/1
Y1 - 2010/1/1
N2 - To evaluate the prognostic value of preoperative serum tetranectin (TN) in Danish ovarian cancer (OvCa) patients. Design. Population-based, multidisciplinary Danish case-control study of OvCa.
AB - To evaluate the prognostic value of preoperative serum tetranectin (TN) in Danish ovarian cancer (OvCa) patients. Design. Population-based, multidisciplinary Danish case-control study of OvCa.
U2 - http://dx.doi.org/10.3109/00016340903530936
DO - http://dx.doi.org/10.3109/00016340903530936
M3 - Journal article
VL - 89
SP - 190
EP - 198
JO - Acta Obstetricia et Gynecologica Scandinavica
JF - Acta Obstetricia et Gynecologica Scandinavica
SN - 0001-6349
IS - 2
ER -
